Comparative Evaluation of Lipid Profiles and Cardiac Risk Markers in Obese and Non-Obese Patients Attending a Cardiology Clinic
Antiemetic Protocols for PONV in Abdominal Surgery
DOI:
https://doi.org/10.69750/dmls.02.03.0114Keywords:
Obesity, Dyslipidemias, Lipoproteins, Triglycerides, Cholesterol, LDL, HDL, Apolipoproteins A-I, Risk AssessmentAbstract
Background: Obesity is highly prevalent in Pakistan and contributes to cardiovascular risk by promoting dyslipidemia and low-grade inflammation.
Objectives: To compare fasting lipid profiles and advanced cardiac risk markers—high-sensitivity C-reactive protein (hs-CRP), apolipoprotein B/A-I ratio, and atherogenic index of plasma (AIP)—between obese and non-obese adults attending a cardiology clinic.
Methods: In this comparative cross-sectional study at Sharif Medical City Hospital, Lahore (1st, January 2024 – 31st, December 2025), 35 obese (BMI ≥ 30 kg/m²) and 35 non-obese (BMI < 25 kg/m²) outpatients (30–60 years) without diabetes, hypertension, thyroid dysfunction, recent acute coronary syndrome, chronic inflammation, pregnancy, or lipid-lowering therapy were consecutively enrolled. After a 10–12 h fast, serum total cholesterol, triglycerides, HDL-C, and LDL-C (enzymatic assays); apolipoproteins A-I and B (immunoturbidimetry); and hs-CRP (high-sensitivity immunoturbidimetry) were measured. VLDL-C was estimated as TG/5 and AIP as log₁₀(TG/HDL-C). Independent-samples t-tests and Pearson’s correlations were performed (SPSS v.26; p < 0.05).
Results: Compared with non-obese subjects, the obese group had significantly higher triglycerides (192 ± 48 vs. 144 ± 35 mg/dL), LDL-C (138 ± 30 vs. 119 ± 26 mg/dL), VLDL-C (38 ± 10 vs. 29 ± 7 mg/dL), and total cholesterol (214 ± 36 vs. 196 ± 32 mg/dL; all p ≤ 0.02), and lower HDL-C (37 ± 9 vs. 52 ± 11 mg/dL; p < 0.001). Hs-CRP (4.0 ± 1.4 vs. 1.9 ± 0.8 mg/L), ApoB/A-I ratio (0.96 ± 0.22 vs. 0.64 ± 0.17), and AIP (0.69 ± 0.20 vs. 0.46 ± 0.15) were markedly elevated in the obese cohort (all p < 0.001).
Conclusion: In this Pakistani cardiology population, obesity is associated with an atherogenic lipid profile, heightened systemic inflammation, and unfavourable lipoprotein ratios. Incorporation of these advanced markers into routine risk assessment may improve early identification of high-risk patients.
Downloads
References
Taqiuddin R, Gupta H, Sufian Z, Kamaluddin K, El Rashid Mohamed YA, Khan A, et al. Cardiovascular risk evaluation using lipid profile and blood pressure among obese and non-obese individuals in India. Bioinformation. 2024;20(7):723-7. doi:10.6026/973206300200723
Bhalothia A, Verma R, Mehra P, Dinesh K, Barolia D. A comparative study of lipid profile in obese and non-obese subjects. World J Pharm Res. 2021;10(11):2477-87. doi:10.20959/wjpr202111-21654
Lokesh S, Kadavanu TM, Green SR, Dutta TK, Hemachandar R, Ramachandrappa AK, et al. A comparative study of lipid profile and cardiovascular risk biomarkers among chronic haemodialysis patients and healthy individuals. J Clin Diagn Res. 2016;10(9):OC15-9. doi:10.7860/JCDR/2016/21897.8523
Sugumaran V, Jagadeesan AR, Ramalingam J. A comparative study of lipid profile in obese and non-obese men attending master health check-up. Indian J Med Biochem. 2017;21(1):73-5. doi:10.5005/jp-journals-10054-0024
Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38(3):789-95. doi:10.1016/S0735-1097(01)01448-6
Bays HE, Kirkpatrick C, Maki KC, Toth PP, Morgan RT, Tondt J, et al. Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the Obesity Medicine Association and the National Lipid Association 2024. Obes Pillars. 2024;10:100108. doi:10.1016/j.obpill.2024.100108
Chaudhary H, Waheed A, Hassan MA, Gillani SKS, Maqsood M, Raza MZ. Comparative evaluation of lipid profile and inflammation for prediction of cardiac medical complications. Prognostic value of lipid profiles and inflammation in cardiovascular disease. Dev Med Life Sci. 2024;1(6):4-11. doi:10.69750/dmls.01.06.057
Zoair AM, Muhammad KT, Abu-Ammo DE, Motawea MM. Lipid profile and some cardiac functions in children with obesity. Egypt Pediatr Assoc Gaz. 2013;61(1):15-22. doi:10.1016/j.epag.2013.04.005
Abera A, Worede A, Hirigo AT, Alemayehu R, Ambachew S. Dyslipidemia and associated factors among adult cardiac patients: a hospital-based comparative cross-sectional study. Eur J Med Res. 2024;29(1):237. doi:10.1186/s40001-024-01802-x
Spannella F, Giulietti F, Di Pentima C, Sarzani R. Prevalence and control of dyslipidemia in patients referred for high blood pressure: the disregarded “double-trouble” lipid profile in overweight/obese. Adv Ther. 2019;36(6):1426-37. doi:10.1007/s12325-019-00941-6
Gebrie A, Gnanasekaran N, Menon M, Sisay M, Zegeye A. Evaluation of lipid profiles and hematological parameters in hypertensive patients: laboratory-based cross-sectional study. SAGE Open Med. 2018;6:2050312118756663. doi:10.1177/2050312118756663
Moussavi Javardi MS, Madani Z, Movahedi A, Karandish M, Abbasi B. Correlation between dietary fat quality indices and lipid profile with atherogenic index of plasma in obese and non-obese volunteers: a case-control study. Lipids Health Dis. 2020;19(1):213. doi:10.1186/s12944-020-01387-4
Welsh A, Hammad M, Piña IL, Kulinski J. Obesity and cardiovascular health. Eur J Prev Cardiol. 2024;31(8):1026-35. doi:10.1093/eurjpc/zwae025
Alshuweishi Y, Almufarrih AA, Abudawood A, Alfayez D, Alkhowaiter AY, AlSudais H, et al. Patterns of lipid abnormalities in obesity: a comparative analysis in normoglycemic and prediabetic obese individuals. J Pers Med. 2024;14(9):980. doi:10.3390/jpm14090980
El Missiri A, Abdel Halim WA, Almaweri AS, Mohamed TR. Effect of a phase 2 cardiac rehabilitation program on obese and non-obese patients with stable coronary artery disease. Egypt Heart J. 2021;73(1):4. doi:10.1186/s43044-020-00119-4
Jaidev A, Shah H, Chaturvedi MK. Gender-based differences in lipid profile and novel atherogenic risk factors in type 2 diabetes mellitus. Int J Res Med Sci. 2021;9(10):3099-104. doi:10.18203/2320-6012.ijrms20213940
Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143(21):e984-1010. doi:10.1161/CIR.0000000000000973
Osuji CU, Omejua EG, Onwubuya EI, Ahaneku GI. Serum lipid profile of newly diagnosed hypertensive patients in Nnewi, South-East Nigeria. Int J Hypertens. 2012;2012:710486. doi:10.1155/2012/710486
Ayoade OG, Umoh I, Amadi C. Dyslipidemia and associated risk factors among Nigerians with hypertension. Dubai Med J. 2020;3(4):155-61. doi:10.1159/000509570
Bays HE, Kirkpatrick CF, Maki KC, Toth PP, Morgan RT, Tondt J, et al. Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the Obesity Medicine Association and the National Lipid Association 2024. J Clin Lipidol. 2024;18(3):e320-50. doi:10.1016/j.jacl.2024.04.001
Downloads
PlumX Metrics
Published
Issue
Section
How to Cite
